Rice University

Rice University is a private research institution located in Houston, Texas, established in 1912. It emphasizes education across various fields, including humanities, sciences, and engineering, creating an environment that fosters diversity and intellectual growth. The university prioritizes close relationships between students and faculty, facilitating personalized academic experiences that enhance learning and research initiatives. Through its commitment to academic excellence, Rice University supports a wide range of programs, including scholarships, professorships, and fellowships, contributing to both basic research and public service initiatives.

8 past transactions

Greentown Labs

Debt Financing in 2024
Greentown Labs, Inc. is a climate technology incubator founded in 2011 and located in Somerville, Massachusetts. The company provides co-located prototyping, office, and event spaces specifically designed for businesses in the clean technology, energy, and environmental sectors. Its mission is to foster a vibrant community of entrepreneurs by offering the necessary resources and support to help early-stage companies thrive. By creating shared warehouse spaces and facilitating collaboration, Greentown Labs aims to enable innovative solutions that address pressing climate challenges.

Greentown Labs

Grant in 2024
Greentown Labs, Inc. is a climate technology incubator founded in 2011 and located in Somerville, Massachusetts. The company provides co-located prototyping, office, and event spaces specifically designed for businesses in the clean technology, energy, and environmental sectors. Its mission is to foster a vibrant community of entrepreneurs by offering the necessary resources and support to help early-stage companies thrive. By creating shared warehouse spaces and facilitating collaboration, Greentown Labs aims to enable innovative solutions that address pressing climate challenges.

Mallard Bay

Grant in 2022
Mallard Bay operates an online marketplace designed for sportsmen seeking to book reliable hunting and fishing experiences. The platform allows users to discover and compare guided trips, facilitating secure payment processing and connecting clients with reputable guides and outfitters. Additionally, Mallard Bay offers back-office solutions that assist these services in showcasing their offerings, managing bookings, and processing payments. This comprehensive approach enables outdoor enthusiasts to easily access and enjoy their adventures in a streamlined manner.

TransCrypts

Seed Round in 2021
TransCrypts is a platform designed to assist Human Resource Departments in automating the issuance of employment and income verification documents. By utilizing blockchain technology, TransCrypts streamlines the creation and distribution of these documents, delivering them directly to employees on a monthly basis. This innovative approach not only enhances compliance with verification requirements but also empowers employees with greater control over their work-related information. The platform aims to alleviate the administrative burdens faced by HR departments, ultimately saving time and resources.

Randian

Seed Round in 2019
RANDIAN LLC is an innovative company based in Sherman Oaks, California, that offers an interactive shopping network designed to enhance the viewing experience of shows and videos. By integrating a patented platform with e-commerce capabilities, RANDIAN allows users to engage with content while shopping for clothing worn by their favorite characters. Viewers can click on items to access descriptions and add them to their shopping cart, creating a seamless blend of entertainment and retail. This platform not only benefits consumers but also provides valuable insights to brands and content creators about audience behavior, ultimately driving direct sales and transforming traditional advertising methods in the digital landscape.

OncoResponse

Series B in 2018
OncoResponse Inc. is an immuno-oncology biotechnology company based in Houston, Texas, focused on developing innovative cancer therapies. The company utilizes a proprietary human antibody platform to identify fully human monoclonal antibodies targeting immuno-oncology pathways. By probing the adaptive immune systems of cancer patients who have shown exceptional responses to checkpoint inhibitors, OncoResponse aims to discover novel therapeutic antibodies. Its research emphasizes addressing immunosuppressive myeloid biology and enhancing immune activation, with the goal of transforming cold tumors into hot tumors that are more responsive to treatment. Through its advanced antibody pipeline, OncoResponse is dedicated to providing effective solutions for cancer treatment.

Medical Magnesium

Seed Round in 2017
Medical Magnesium specializes in developing metallic bioabsorbable implants specifically designed for orthopedic and trauma surgery. These innovative implants are both mechanically stable and physiologically degradable, allowing them to dissolve after fracture healing, which eliminates the need for subsequent metal removal surgeries. The company aims to provide tailor-made, highly functional magnesium-based solutions that enhance surgical outcomes and streamline recovery processes for patients. Originating from RWTH Aachen University, Medical Magnesium leverages interdisciplinary research in engineering and medicine to create advanced implant technologies. The implants not only stabilize fracture healing but also release nutrients that aid in regrowing the natural bone structure, ultimately improving patient care and recovery times in clinical settings.

OncoResponse

Series A in 2016
OncoResponse Inc. is an immuno-oncology biotechnology company based in Houston, Texas, focused on developing innovative cancer therapies. The company utilizes a proprietary human antibody platform to identify fully human monoclonal antibodies targeting immuno-oncology pathways. By probing the adaptive immune systems of cancer patients who have shown exceptional responses to checkpoint inhibitors, OncoResponse aims to discover novel therapeutic antibodies. Its research emphasizes addressing immunosuppressive myeloid biology and enhancing immune activation, with the goal of transforming cold tumors into hot tumors that are more responsive to treatment. Through its advanced antibody pipeline, OncoResponse is dedicated to providing effective solutions for cancer treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.